Bright Minds Biosciences (DRUG) Q2 2024 Earnings
DRUG·Reported August 14, 2024·Before market open
Diluted EPS came in at $0.04.
Diluted EPS
$0.04
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about Bright Minds Biosciences's Q2 2024 earnings report.
Bright Minds Biosciences (DRUG) reported Q2 2024 earnings on August 14, 2024 before market open.
Bright Minds Biosciences reported diluted EPS of $0.04 for Q2 2024.